Sonya L Heltshe

7PUBLICATIONS
15CO-AUTHORS
MortalityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Fluid-structure interaction and aeroacousticsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 24, 2026
Risk factors for longitudinal estimated glomerular filtration rate decline in adults with cystic fibrosis.

Deepthi Nacharaju, Leila R Zelnick, Kathleen J Ramos

|Jun 25, 2024
Statistical approaches for the integration of external controls in a cystic fibrosis clinical trial: a simulation and an application.

Mark N Warden, Sonya L Heltshe, Noah Simon

|Oct 12, 2019
Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.

J Kirk Harris, Brandie D Wagner, Edith T Zemanick

|Dec 25, 2018
CFTR Modulator Use Is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis.

Alex H Gifford, Sonya L Heltshe, Christopher H Goss

|Jan 16, 2016
Optimising treatment of CF pulmonary exacerbation: a tough nut to crack.

Sonya L Heltshe, Christopher H Goss

Pageof 2